Bernstein Liebhard LLP Launches Testosterone Treatment Lawsuit Website to Inform Men about Recent FDA Alert, Recent AndroGel Case Filings - WECT TV6-WECT.com:News, weather & sports Wilmington, NC

Bernstein Liebhard LLP Launches Testosterone Treatment Lawsuit Website to Inform Men about Recent FDA Alert, Recent AndroGel Case Filings

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Bernstein Liebhard LLP

NEW YORK, Feb. 14, 2014 /PRNewswire/ -- Following a number of recent testosterone treatment lawsuit (http://www.testosteronelawsuitcenter.com/) filings and an alert from the U.S. Food & Drug Administration (FDA), Bernstein Liebhard LLP has published a new website for patients who may have experienced a life-threatening heart injury caused by certain prescription therapies.

(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO )

Among other things, the Firm's new site will provide information about the below testosterone treatment medications, which have been allegedly associated with strokes, heart attacks and other cardiovascular events:

  • Axiron
  • AndroDerm
  • AndroGel
  • Bio-T Gel
  • Delatestryl
  • Depo-Testosterone
  • Foresta
  • Striant
  • Testopel
  • Testim

The possible link between prescription testosterone treatments like AndroGel and the risk for serious cardiovascular events most recently made headlines in January 2014, when the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication alerting the public of its plans to conduct a safety review of the drugs. Although this FDA notification came at the heels of research that lent evidence to the possibility that certain prescription testosterone therapies may cause strokes, heart attacks, and other cardiovascular events, no concrete conclusions regarding the association have been reached. 

"News of this FDA alert, coupled with the recent testosterone treatment lawsuits that have been filed in U.S. courts are of great interest to our Firm, which is why we felt it was imperative to create a website providing the general public with access to updates on the issue," says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free and confidential case reviews to individuals who may have suffered heart attacks, strokes, deep vein thrombosis or pulmonary embolism after taking certain testosterone treatment therapies.

Testosterone Treatment Lawsuits

Starting in November 2013, concerns about certain testosterone treatments allegedly causing heart problems have continued to grow. The Journal of the American Medical System published a study that month finding that older men with pre-existing heart conditions may be at an increased risk for strokes, heart attacks and other heart problems. This conclusion was later followed up in January 2014 when research published in PLOS One showed that younger men with pre-existing heart problems may be at a doubled risk for suffering heart attacks caused by testosterone treatment therapies, as were all men over the age of 65.

Since the FDA alert was issued last month, four AndroGel lawsuit claims alleging injuries caused by the drug have been filed in the U.S. District Court for the Northern District of Illinois. These cases accuse the testosterone treatment's manufacturer of using direct-to-consumer advertising to create demand for its product, which is often prescribed to treat fatigue, low libido, and other symptoms associated with aging. Prescribing AndroGel to men with normal levels of testosterone may be considered an off-label use, according to claims, as the testosterone treatment is only approved by the FDA to treat low levels of testosterone in patients with another medical condition. (Case Nos: 1:14-cv-00776, 1:14-cv-00780, 1:14-cv-00777, and 1:14-cv-00772)

Men who may have suffered strokes, heart attacks or another serious cardiovascular event after taking AndroGel or another one of the above prescription testosterone treatment therapies may be eligible to file a lawsuit seeking compensation from its manufacturer. Learn more about filing a testosterone treatment lawsuit by calling our Firm today at (888) 340-4807.

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the "Plaintiffs' Hot List," recognizing the top plaintiffs' firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
(888) 340-4807

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (888) 340-4807. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:  
Felecia L. Stern, Esq. 
Bernstein Liebhard LLP 
info (at) consumerinjurylawyers (dot) com 
http://www.testosteronelawsuitcenter.com/ 
https://plus.google.com/115936073311125306742?rel=author

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow